Further studies, conducted in various age groups and including estimates of the degree of lung destruction, are needed to unravel the mechanisms underlying lysis and resynthesis of lung elastin. (Thorax 1992;47:937-942) The protease-antiprotease imbalance theory, derived from the discovery of a, protease inhibitor deficiency linked to an increased risk of emphysema' and from animal models of emphysema induced by proteases,2 has been proposed to explain lung destruction in pulmonary emphysema. Although this theory explains the pathogenesis of emphysema in patients who are homozygous for PI Z a, protease inhibitor deficiency, it is still not clear whether the same mechanisms underly smoker's emphysema, the most common form of the disease.3 Elastin metabolism may be affected by risk factors, such as smoking, both through an increased elastin degradation and through a reduction in the capacity of the lung to repair itself.34 The use of potential biological markers of elastin metabolism in body fluids has been proposed as an approach to the pathogenesis of emphysema. Desmosine, a cross linking amino acid of elastin and a potential marker of elastin degradation, was not found to be increased in clinically defined emphysema5 or with smoking,6 nor was it related to the FEV1.6 Besides desmosine, the plasma7 or serum8 elastin peptide concentration has been reported in clinical studies to be higher among patients with chronic obstructive pulmonary disease than among healthy subjects78 and higher in smokers than non-smokers.7 An increased elastin peptide concentration would therefore be related to markers and potential risk factors of emphysema. This hypothesis was tested in an epidemiological study exploring the relation of serum elastin peptide concentration to-some factors closely related to pulmonary emphysema (age, smoking habits, FEVI, protease inhibitor phenotype) and to alcohol consumption, a potential cause of poorer lung function,9 10 which had previously been shown to be related to a decreased al protease inhibitor activity in the population studied." 
(PI) phenotype) and to alcohol consumption was examined in an epidemiological study of 310 working men. The elastin peptides used for obtaining antibodies and as reference in an ELISA assay were prepared from chemically hydrolysed elastin. Results The elastin peptide concentration significantly decreased with age from (1-54) pg/ml among subjects younger than 30 years to 2-18 (1- 14) ,g/ml among subjects older than 50. Elastin peptide concentration did not differ with smoking habits and was clearly unrelated to FEV,.
A lower elastin peptide concentration was observed in all groups of subjects with a protease inhibitor phenotype other than PI MM (PI FM, IM, MP, MS, MZ, and S phenotypes). Conclusions The results cast doubts on the usefulness of the elastin peptide concentration as a marker of lung destruction in middle aged, predominantly healthy men. Blood elastin peptide concentration may reflect both elastin degradation and resynthesis. The results of this analysis suggest that several factors (age, alcohol consumption, non-PI MM phenotype) may be associated with decreased resynthesis of lung elastin.
Further studies, conducted in various age groups and including estimates of the degree of lung destruction, are needed to unravel the mechanisms underlying lysis and resynthesis of lung elastin. (Thorax 1992; 47:937-942) The protease-antiprotease imbalance theory, derived from the discovery of a, protease inhibitor deficiency linked to an increased risk of emphysema' and from animal models of emphysema induced by proteases,2 has been proposed to explain lung destruction in pulmonary emphysema. Although this theory explains the pathogenesis of emphysema in patients who are homozygous for PI Z a, protease inhibitor deficiency, it is still not clear whether the same mechanisms underly smoker's emphysema, the most common form of the disease.3 Elastin metabolism may be affected by risk factors, such as smoking, both through an increased elastin degradation and through a reduction in the capacity of the lung to repair itself.34 The use of potential biological markers of elastin metabolism in body fluids has been proposed as an approach to the pathogenesis of emphysema. Desmosine, a cross linking amino acid of elastin and a potential marker of elastin degradation, was not found to be increased in clinically defined emphysema5 or with smoking,6 nor was it related to the FEV1.6 Besides desmosine, the plasma7 or serum8 elastin peptide concentration has been reported in clinical studies to be higher among patients with chronic obstructive pulmonary disease than among healthy subjects78 and higher in smokers than non-smokers. 7 The elastin peptide concentration was measured in serum by an enzyme linked immunosorbent assay (ELISA). The elastin peptides used for obtaining antibodies and as reference in the assay were prepared from human aorta elastin hydrolysed with 1 M KOH in 80% aqueous ethanol (kappa (K) elastin). The indirect ELISA procedure we used, described in detail elsewhere,'7 was found to give specific and reproducible results (coefficient of variation 8-5%). Samples were run in triplicate. The assay was sensitive from 0-3 pg to 220 pg of K elastin equivalents per ml of serum. Results were expressed as K elastin equivalents per ml of serum. Elastin peptide concentration scores were elastin peptide concentration normalised as the elastin peptide concentration -(d [age] + e)/1Is2, where d is the age regression coefficient, e the intercept, and s2 the residual variance.
Analysis of variance, correlation, and multiple linear regression were used for the analysis. 8 
Results
No difference between the 310 men of our population sample and the 280 men lost to follow up was observed for age and smoking habits at the first survey. The subjects per cent of the subjects had a FEVy lower than 80% of the reference predicted FEVy. Seven per cent of the men were asthmatic, 7% reported sputum production, and 17% reported dyspnoea grade 1. Nineteen per cent of our subjects were heavy smokers ( > 20 g/day) and 12% of them were heavy drinkers (>60 g alcohol/day). Elastin peptide concentration, if we exclude one outlier value of 13-27 pg/ml, ranged from 0-14 to 7-24 pg/ml, with a mean (SD) of 2 55 (1 34) pg/ml. The subject with the outlier value (whose phenotype was PI MM) did not differ from others in age, smoking, drinking habits, or FEVI. Analyses were performed before and after excluding this outlier value and our conclusions were unchanged.
The results presented therefore include all values.
As shown in figure 1, elastin peptide concentration decreased with age (regression coefficient ofelastin peptide concentration with age -0-03; p < 0 005). The elastin peptide concentration fell progressively across the age groups, being 2,92 (1-54), 2-69 (1-26), 2-55
(1 42), and 2-18 (1-14) ug/ml among subjects aged under 30, 30 < age < 40, 40 < age < 50, and age > 50 years (p < 0 05).
The highest mean elastin peptide concentration was observed among ex-smokers and the lowest among heavy smokers, with intermediate values among non-smokers and moderate smokers (table 1) . There was no clear pies.5 78 19 The lack of standardisation in measurement of elastin peptide concentration has led to heterogeneity of the values of these markers reported in the various studies, which have differed by a factor of 1000.7 817 Comparison between the various studies is difficult because results are expressed in different units7 82 and the elastin peptides identified by the various assays may differ. The ELISA procedure we used was found to give specific and reproducible results. The method avoids potential contamination of elastin peptide with elastase, which may occur when elastase is used for elastin hydrolysis, a method used in some other studies.7
AGE
The inverse relation between age, a factor highly related to emphysema,22 and elastin peptide concentration observed in our population, aged 28-58 years, was unexpected. Nobody has reported a decrease of elastin peptide concentration with age-there has been either no relation or an increase in concentration with age. 7 1720 23 The discrepancies observed in the various studies concerning the relation of elastin peptide to age may be accounted for by differences in the selection of subjects. 
SMOKING HABITS
We did not detect any variation of elastin peptide concentration with different smoking habits, a finding similar to that of study8 of 16 subjects with an age range similar to that of our study. These results are at variance with those of Kucich et al, who observed a significantly higher elastin peptide concentration among 51 smokers than among 83 non-smokers.7 Changes in smoking habits cannot explain our findings as an analysis restricted to subjects with unchanged habits for at least five years gave the same results. An association between smoking habits and elastin peptide concentration could, however, be observed at an older age. On the assumption of an exclusive acute effect of smoking on lung destruction, measurement of cotinine, which precisely assesses exposure over the previous 24 hours, would be of interest in future studies, or perhaps nicotine, which assesses exposure over the last few hours. The immunological assay used here measured elastin peptide concentration in the peripheral blood, which may be different from that in the lung. A continuous slightly increased degradation of lung elastin, due to tobacco, may be difficult to detect in peripheral blood because of a high background of extrapulmonary elastin turnover. Alternatively, these findings may suggest an episodic elastin degradation, which is acute and therefore only occasionally detectable. The hypothesis of a succession of acute events has already been put forward to explain the lack of difference in urine desmosine measurements between normal and emphysematous adults with cx, protease inhibitor deficiency5 and the previously observed large day to day variation. Epidemiological reports have shown that only heavy9 alcohol consumption is associated with the longitudinal decline in FEVI, independently of smoking. By contrast, a protective effect of alcohol on emphysema was reported in a study of non-selected. 26 We observed that heavy (but not moderate) alcohol consumption was related.,to a lower elastin peptide concentration, an association still of borderline significance after adjustment for age. The relation between a, protease inhibitor (synthesised by the liver) and tobacco and alcohol consumption was investigated in the 1980 survey conducted in our population." Alcohol but not tobacco consumption was inversely correlated with the functionally active a, protease inhibitor concentratio. 116 This suggests that alcohol has a deleterious effect on the lung by decreasing the antielastase protection. A decrease of the neutrophil elastase activity with alcohol consumption was also reported, however, suggesting that a protective effect of alcohol on emphysema in smokers may be due to the effects of alcohol on marrow precursors of neutrophils.27 Two studies have already reported that smokers with heavy alcohol consumption had better lung function values than non drinking subjects.910 Such results would suggest a protective role ofalcohol among smokers. Additional studies are required to understand the complex interrelation between emphysema, elastase and antielastase activities, tobacco and alcohol consumption.
PROTEASE INHIBITOR PHENOTYPE
We did not observe any increase in elastin peptide concentration among subjects with a partial a, protease inhibitor deficiency (PI MS, MZ, and S subjects, whose theoretical concentration ranges from 60% to 80% of the normal mean). On the contrary, the group of PI MS, MZ, and S subjects had a lower elastin peptide concentration than other subjects. The relation between protease inhibitor phenotype and elastin peptide concentration is still uncertain and no interpretation of the decrease of elastin peptide concentration observed among subjects with the FM, IM, MP, MS, MZ, and S phenotypes can be proposed.
Interpretation of our results is limited by the fact that elastin metabolism is not fully understood. The observation that patients with chronic obstructive lung disease had higher elastin peptide concentration than healthy subjects7 suggested that the elastin peptide concentration might be a marker of lung elastin degradation. To our knowledge no stable pool of elastin is present in blood. 28 Resynthesis of elastin could explain the increase in activity of the enzyme cross linking elastin (lysyl oxidase), which was observed after elastase injury in animal studies.29 Such a resynthesis may be affected by smoking, among other factors, as suggested by the observation that lysyl oxidase activity was impaired in smoking animals. 4 Animal experiments, together with the observation that the elastin content of human emphysematous lungs is normal, 30 
